Biotech · Private company
GlycoMimetics Incorporated
Track this companyFree. Adds GlycoMimetics Incorporated to your Dealase workspace and tells you when its record changes.
Clinical trials170 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- RivipanselPhase 3 · Sickle Cell AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- UproleselanPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CytarabinePhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- Enoxaparin Sodium (Lovenox®)Phase 2 · Deep Venous ThrombosisClinicalTrials.gov · fetched Nov 12, 2026
- EtoposidePhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- GMI-1070Phase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- GMI-1271Phase 2 · Deep Venous ThrombosisClinicalTrials.gov · fetched Nov 12, 2026
- GMI-1271Phase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- IdarubicinPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- MitoxantronePhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- GMI-1359Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- GMI-1359Phase 1 · HR+ Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- RivipanselPhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- RivipanselPhase 1 · Moderate Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- RivipanselPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials17
- Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AMLPHASE1 · TERMINATED · started Oct 6, 2022ClinicalTrials.gov NCT05569512 · fetched Nov 12, 2026
- Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 PneumoniaPHASE1_PHASE2 · TERMINATED · started Nov 12, 2021ClinicalTrials.gov NCT05057221 · fetched Nov 12, 2026
- Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid LeukemiaPHASE1 · TERMINATED · started Jul 2, 2021ClinicalTrials.gov NCT04964505 · fetched Nov 12, 2026
- Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)PHASE2 · COMPLETED · started May 5, 2021ClinicalTrials.gov NCT04682405 · fetched Nov 12, 2026
- A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast CancerPHASE1 · TERMINATED · started Nov 21, 2019ClinicalTrials.gov NCT04197999 · fetched Nov 12, 2026
- Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid LeukemiaPHASE3 · TERMINATED · started Oct 15, 2018ClinicalTrials.gov NCT03616470 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.PHASE1 · COMPLETED · started Jan 1, 2017ClinicalTrials.gov NCT02998099 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic FunctionPHASE1 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02871570 · fetched Nov 12, 2026
- Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy VolunteersPHASE1 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02931214 · fetched Nov 12, 2026
- Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)PHASE1_PHASE2 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02744833 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy SubjectsPHASE1 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02813798 · fetched Nov 12, 2026
- Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell DiseasePHASE3 · TERMINATED · started Dec 16, 2015ClinicalTrials.gov NCT02433158 · fetched Nov 12, 2026
- Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell DiseasePHASE3 · COMPLETED · started Jun 17, 2015ClinicalTrials.gov NCT02187003 · fetched Nov 12, 2026
- Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AMLPHASE1_PHASE2 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02306291 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult SubjectsPHASE1 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01941511 · fetched Nov 12, 2026
- Study of GMI-1070 for the Treatment of Sickle Cell Pain CrisisPHASE2 · COMPLETED · started May 1, 2010ClinicalTrials.gov NCT01119833 · fetched Nov 12, 2026
- Study of Intravenous GMI-1070 in Adults With Sickle Cell DiseasePHASE1_PHASE2 · COMPLETED · started May 1, 2009ClinicalTrials.gov NCT00911495 · fetched Nov 12, 2026